Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
Royal Marsden NHS Foundation Trust
University of Chicago
University of Erlangen-Nürnberg Medical School
Sotio Biotech Inc.
University of Washington
Pfizer
Pfizer
Novartis
MacroGenics
Flamingo Therapeutics NV
M.D. Anderson Cancer Center
University of Arizona
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Institut de cancérologie Strasbourg Europe
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Alpha Tau Medical LTD.
Regeneron Pharmaceuticals
Takeda
Gilead Sciences
AbbVie
HiFiBiO Therapeutics
M.D. Anderson Cancer Center
EMD Serono
Novartis
Sanofi
Pfizer
BeiGene
University of Southern California
Incyte Corporation
3B Pharmaceuticals GmbH
Ascendis Pharma A/S
MacroGenics
Yale University
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
invoX Pharma Limited
Eli Lilly and Company
Formation Biologics
PhytoHealth Corporation
Pfizer
Numab Therapeutics AG
Regeneron Pharmaceuticals
Groupe Oncologie Radiotherapie Tete et Cou
Thomas Jefferson University
M.D. Anderson Cancer Center
Kymab Limited
Wake Forest University Health Sciences
Seagen Inc.